Practical Reviews

LCIS Is Not Cancer, But It's Not Benign Either


Background: The pathologic diagnosis of lobular carcinoma in situ (LCIS) is a frustrating result of core needle biopsy since there is no clear well-documented approach in the subsequent management of these patients. LCIS has been shown to increase the patient's overall chance of developing breast cancer over the course of her lifetime, but there is no widely accepted method on how to deal with this possibility. Objective: To evaluate the efficacy of surgical excisional biopsy after more...
ABSTRACT VIEW
To view this content, you must be a logged in subscriber to PracticalReviews.com.
Please Login to view this content.